{"id":5706,"date":"2024-05-22T20:05:15","date_gmt":"2024-05-22T20:05:15","guid":{"rendered":"https:\/\/dnc-test.myddns.me\/cda-foundation\/cdafound.org\/?page_id=5706"},"modified":"2024-10-02T18:24:54","modified_gmt":"2024-10-02T18:24:54","slug":"board-of-directors","status":"publish","type":"page","link":"https:\/\/dnc-test.myddns.me\/cda-foundation\/cdafound.org\/board-of-directors\/","title":{"rendered":"Board of Directors"},"content":{"rendered":"<div class=\"tmm tmm_board-of-directors tmm-floating-pic\"><div class=\"tmm_2_columns tmm_wrap tmm_theme_f\"><span class=\"tmm_two_containers_tablet\"><\/span><div class=\"tmm_container tmm-equalizer\"><div class=\"tmm_member tmm_theme_f\" style=\"border-top:#860a0e solid 100px;\"><div class=\"tmm_circular-borders  tmm_photo tmm_pic_board-of-directors_0\" style=\"background: url(https:\/\/dnc-test.myddns.me\/cda-foundation\/cdafound.org\/wp-content\/uploads\/2024\/10\/Gregg-hs-square.jpg); margin-left: auto; margin-right:auto; background-size:cover !important;\"><\/div><div class=\"tmm_textblock\"><div class=\"tmm_names\"><span class=\"tmm_fname\">Gregg<\/span> <span class=\"tmm_lname\">Alton<\/span><\/div><div class=\"tmm_job\">CDAF<\/div><div class=\"tmm_desc\" style=\"text-align:\"><p>Mr. Alton spent more than 20 years at Gilead Sciences, where he served in an array of leadership roles across a portfolio of responsibilities. From January 2019 until March 2019, Mr. Alton was Gilead\u2019s interim chief executive officer. Prior to that, he was the company\u2019s chief patient officer, responsible for Gilead\u2019s government affairs, public affairs, patient outreach, and engagement initiatives, as well as efforts to facilitate access to its medicines around the world.<\/p><\/div><div style=\"margin-top:10px; margin-bottom:15px; color:#860a0e\" class=\"tmm_more_info\"><div class=\"tmm_comp_text tmm_comp_text_bright\">During his tenure at Gilead, his wide-ranging roles included leadership of commercial operations in Europe, Asia, Latin America, and Africa, as well as global medical affairs. He also served as general counsel and chief compliance officer. Prior to joining Gilead, Mr. Alton was an attorney at the law firm of Cooley Godward, LLP, where he specialized in corporate finance transactions for healthcare and information technology companies. Mr. Alton previously served on the United States Presidential Advisory Council on HIV\/AIDS, is a member of the board of directors of Novavax Inc., Brii Biosciences, Corcept Therapeutics, and several non-profit organizations, including The Hepatitis Fund, ETR and the Boys and Girls Clubs of Oakland and the Global Antibiotic Research &amp; Developement Partnership. Mr. Alton received a bachelor\u2019s degree in legal studies from the University of California at Berkeley and a law degree from Stanford University.<\/div><span class=\"button\">Read More<\/span><\/div><div class=\"tmm_scblock\"><\/div><\/div><\/div><div class=\"tmm_member tmm_theme_f\" style=\"border-top:#860a0e solid 100px;\"><div class=\"tmm_circular-borders  tmm_photo tmm_pic_board-of-directors_1\" style=\"background: url(https:\/\/dnc-test.myddns.me\/cda-foundation\/cdafound.org\/wp-content\/uploads\/2024\/10\/Lisa-square.jpg); margin-left: auto; margin-right:auto; background-size:cover !important;\"><\/div><div class=\"tmm_textblock\"><div class=\"tmm_names\"><span class=\"tmm_fname\">Lisa<\/span> <span class=\"tmm_lname\">Bright<\/span><\/div><div class=\"tmm_job\">CDAF<\/div><div class=\"tmm_desc\" style=\"text-align:\"><p>Lisa has over 35 years of experience in the Pharmaceutical and Life Science Industry. She is Chair of Resolution Therapeutics Ltd and a Non-Executive Board Member of several listed and private companies including Dechra Pharmaceuticals PLC, Ascendis Pharma A\/S, Immedica Pharma AB. Lisa also advises Syncona Ltd and DRI Capital. In her executive career she was Chief Commercial &amp; Corporate Affairs Officer and President of International for Intercept Pharmaceuticals.<\/p><\/div><div style=\"margin-top:10px; margin-bottom:15px; color:#860a0e\" class=\"tmm_more_info\"><div class=\"tmm_comp_text tmm_comp_text_bright\">Prior to this, Lisa held various senior roles at Gilead Sciences, Inc and GlaxoSmithKline plc, including Regional General Management, Government Affairs, and sales and marketing. She has particular expertise in HIV, HBV and HCV. Prior to this, Lisa also worked at Sanofi from 1992 to 1996 and GlaxoSmithKline from 1989 to 1992. She received her B.Sc. in Pharmacology from University College London, United Kingdom.<\/div><span class=\"button\">Read More<\/span><\/div><div class=\"tmm_scblock\"><\/div><\/div><\/div><span class=\"tmm_two_containers_tablet\"><\/span><\/div><span class=\"tmm_columns_containers_desktop\"><\/span><div class=\"tmm_container tmm-equalizer\"><div class=\"tmm_member tmm_theme_f\" style=\"border-top:#860a0e solid 100px;\"><div class=\"tmm_circular-borders  tmm_photo tmm_pic_board-of-directors_2\" style=\"background: url(https:\/\/dnc-test.myddns.me\/cda-foundation\/cdafound.org\/wp-content\/uploads\/2024\/10\/Lily-square.jpg); margin-left: auto; margin-right:auto; background-size:cover !important;\"><\/div><div class=\"tmm_textblock\"><div class=\"tmm_names\"><span class=\"tmm_fname\">Dr. Lilian<\/span> <span class=\"tmm_lname\">Lou<\/span><\/div><div class=\"tmm_job\">CDAF<\/div><div class=\"tmm_desc\" style=\"text-align:\"><p>Lily is the President and Program Director of The John C. Martin Foundation, a private nonprofit organization working to bring improved healthcare to socially and economically underserved populations. Prior to the Foundation, she had over 20 years of work experience in the pharmaceutical industry. She directed discovery biology research and clinical studies, and managed regulatory and medical affairs in several pharma and biotech companies focusing on disease areas including viral hepatitis and inflammatory diseases like lupus.<\/p><\/div><div style=\"margin-top:10px; margin-bottom:15px; color:#860a0e\" class=\"tmm_more_info\"><div class=\"tmm_comp_text tmm_comp_text_bright\">She was also responsible for leading the medical science activities in HIV\/AIDS and viral hepatitis especially in resource-challenged countries in Africa, South-Southeast Asia, Eastern Europe and Latin America. Lily earned her PhD in biochemistry from the University of California, Los Angeles, followed by a postdoctoral fellowship at Stanford University.<\/div><span class=\"button\">Read More<\/span><\/div><div class=\"tmm_scblock\"><\/div><\/div><\/div><div class=\"tmm_member tmm_theme_f\" style=\"border-top:#860a0e solid 100px;\"><div class=\"tmm_circular-borders  tmm_photo tmm_pic_board-of-directors_3\" style=\"background: url(https:\/\/dnc-test.myddns.me\/cda-foundation\/cdafound.org\/wp-content\/uploads\/2024\/10\/Petr-square-600.jpg); margin-left: auto; margin-right:auto; background-size:cover !important;\"><\/div><div class=\"tmm_textblock\"><div class=\"tmm_names\"><span class=\"tmm_fname\">Petr Jan<\/span> <span class=\"tmm_lname\">Pajas<\/span><\/div><div class=\"tmm_job\">Nada\u010dn\u00ed fond CDAF<\/div><div class=\"tmm_desc\" style=\"text-align:\"><p>Petr Jan Pajas is a Czech physicist, civic leader, and recognized expert in nonprofit law and civil society development. He studied nuclear and theoretical physics at Charles University in Prague and continued at Lomonosov University in Moscow, graduating in 1963. He began his career at the Institute of Nuclear Research near Prague and held international research appointments in Italy and the United Kingdom. In 1972, following his opposition to the 1968 occupation of Czechoslovakia, he was expelled from the Academy of Sciences.<\/p><\/div><div style=\"margin-top:10px; margin-bottom:15px; color:#860a0e\" class=\"tmm_more_info\"><div class=\"tmm_comp_text tmm_comp_text_bright\">From 1972 to 1990, he worked in urban transportation systems analysis, developing and implementing software for transportation modeling and traffic management. After the Velvet Revolution in 1989, he assumed senior leadership roles with the Czechoslovak Charter 77 Foundation, the Office for the Establishment of Central European University, the Institute of Information Technology of Prague, the Centre for Democracy and Free Enterprise, and the International Consortium for Training of Czech State Officials in EU Affairs. Appointed to lead a governmental committee drafting new legislation on foundations, he played a key role in shaping the post-communist legal framework for civil society. In cooperation with the International Center for Not-for-Profit Law (Washington, DC), he contributed to legislative development in Albania, Hungary, Poland, Russia, Serbia, Croatia, and Slovakia, and has served as an organizational consultant and legal advisor to numerous NGOs. From 2000 to 2018, he was actively involved in the administration of Anglo-American University in Prague, retiring as its President. He is the author of numerous papers, reports, and articles in Czech and English spanning mathematical physics, semiconductor physics, transportation planning, computerized traffic control, civil society law, public administration training, and EU affairs. He has also edited several books and developed software supporting satellite particle measurements, optical material analysis, traffic signal planning, transportation behavior research, and urban planning systems.<\/div><span class=\"button\">Read More<\/span><\/div><div class=\"tmm_scblock\"><\/div><\/div><\/div><span class=\"tmm_two_containers_tablet\"><\/span><\/div><span class=\"tmm_columns_containers_desktop\"><\/span><div class=\"tmm_container tmm-equalizer\"><div class=\"tmm_member tmm_theme_f\" style=\"border-top:#860a0e solid 100px;\"><div class=\"tmm_circular-borders  tmm_photo tmm_pic_board-of-directors_4\" style=\"background: url(https:\/\/dnc-test.myddns.me\/cda-foundation\/cdafound.org\/wp-content\/uploads\/2024\/10\/homie-hs-2024-blue.jpg); margin-left: auto; margin-right:auto; background-size:cover !important;\"><\/div><div class=\"tmm_textblock\"><div class=\"tmm_names\"><span class=\"tmm_fname\">Dr. Homie<\/span> <span class=\"tmm_lname\">Razavi<\/span><\/div><div class=\"tmm_job\">CDAF &amp; Nada\u010dn\u00ed fond CDAF<\/div><div class=\"tmm_desc\" style=\"text-align:\"><p>Homie Razavi is the Founder and Managing Director of the Center for Disease Analysis Foundation.\u00a0 He leads epidemiological and decision-analysis initiatives to quantify disease burden, forecast trends, and support national strategy development in more than 100 countries. His team established the Polaris Observatory, the leading global registry for hepatitis epidemiology and treatment data, which informs policy and tracks progress toward WHO elimination targets.<\/p><\/div><div style=\"margin-top:10px; margin-bottom:15px; color:#860a0e\" class=\"tmm_more_info\"><div class=\"tmm_comp_text tmm_comp_text_bright\">He has over 25 years of experience in decision analysis, with the past 15 years focused on advancing public health strategies for viral hepatitis elimination. His current work emphasizes innovative demonstration projects and sustainable financing models to make hepatitis elimination achievable worldwide. He has authored more than 150 peer-reviewed publications in high-impact journals and holds a PhD in Organic Chemistry and an MBA.<\/div><span class=\"button\">Read More<\/span><\/div><div class=\"tmm_scblock\"><\/div><\/div><\/div><div class=\"tmm_member tmm_theme_f\" style=\"border-top:#860a0e solid 100px;\"><div class=\"tmm_circular-borders  tmm_photo tmm_pic_board-of-directors_5\" style=\"background: url(https:\/\/dnc-test.myddns.me\/cda-foundation\/cdafound.org\/wp-content\/uploads\/2024\/10\/Armin-square.jpg); margin-left: auto; margin-right:auto; background-size:cover !important;\"><\/div><div class=\"tmm_textblock\"><div class=\"tmm_names\"><span class=\"tmm_fname\">Dr. Armin<\/span> <span class=\"tmm_lname\">Rahimi<\/span><\/div><div class=\"tmm_job\">CDAF<\/div><div class=\"tmm_desc\" style=\"text-align:\"><p>Armin is a physician with 26 years of experience specializing in Pain Management, practicing in St. Luke's hospital in Chesterfield, Missouri. He earned his medical degree from Kansas City University of Medicine and Biosciences and completed a residency in Anesthesiology and was a chief resident at Baystate Medical Center in Springfield, Massachusetts. He also completed a fellowship training in Pain Management at Washington University in St. Louis, Missouri. Armin is board certified in both Anesthesiology and Pain Management.<\/p><\/div><div class=\"tmm_scblock\"><\/div><\/div><\/div><span class=\"tmm_two_containers_tablet\"><\/span><\/div><span class=\"tmm_columns_containers_desktop\"><\/span><div class=\"tmm_container tmm-equalizer\"><div class=\"tmm_member tmm_theme_f\" style=\"border-top:#860a0e solid 100px;\"><div class=\"tmm_circular-borders  tmm_photo tmm_pic_board-of-directors_6\" style=\"background: url(https:\/\/dnc-test.myddns.me\/cda-foundation\/cdafound.org\/wp-content\/uploads\/2024\/10\/Tina-square.jpg); margin-left: auto; margin-right:auto; background-size:cover !important;\"><\/div><div class=\"tmm_textblock\"><div class=\"tmm_names\"><span class=\"tmm_fname\">Tina<\/span> <span class=\"tmm_lname\">Shearer<\/span><\/div><div class=\"tmm_job\">CDAF &amp; Nada\u010dn\u00ed fond CDAF<\/div><div class=\"tmm_desc\" style=\"text-align:\"><p>Tina is the co-founder and a director of Kaspian, LLC, a real estate holding company.\u00a0 She is a UCLA trained mindfulness facilitator and is also certified by the International Mindfulness Teachers Association at the professional level. Previously, Tina was a preschool and junior high school teacher, and a preschool director. She holds a certificate from the Monterey Intensive Tutoring in Reading Program and has a BA in Psychology from the University of Colorado, Denver.<\/p><\/div><div class=\"tmm_scblock\"><\/div><\/div><\/div><div style=\"clear:both;\"><\/div><\/div><\/div><\/div>\n","protected":false},"excerpt":{"rendered":"","protected":false},"author":939,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"footnotes":""},"subtheme":[],"class_list":["post-5706","page","type-page","status-publish","hentry"],"acf":[],"_links":{"self":[{"href":"https:\/\/dnc-test.myddns.me\/cda-foundation\/cdafound.org\/wp-json\/wp\/v2\/pages\/5706","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/dnc-test.myddns.me\/cda-foundation\/cdafound.org\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/dnc-test.myddns.me\/cda-foundation\/cdafound.org\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/dnc-test.myddns.me\/cda-foundation\/cdafound.org\/wp-json\/wp\/v2\/users\/939"}],"replies":[{"embeddable":true,"href":"https:\/\/dnc-test.myddns.me\/cda-foundation\/cdafound.org\/wp-json\/wp\/v2\/comments?post=5706"}],"version-history":[{"count":8,"href":"https:\/\/dnc-test.myddns.me\/cda-foundation\/cdafound.org\/wp-json\/wp\/v2\/pages\/5706\/revisions"}],"predecessor-version":[{"id":6032,"href":"https:\/\/dnc-test.myddns.me\/cda-foundation\/cdafound.org\/wp-json\/wp\/v2\/pages\/5706\/revisions\/6032"}],"wp:attachment":[{"href":"https:\/\/dnc-test.myddns.me\/cda-foundation\/cdafound.org\/wp-json\/wp\/v2\/media?parent=5706"}],"wp:term":[{"taxonomy":"subtheme","embeddable":true,"href":"https:\/\/dnc-test.myddns.me\/cda-foundation\/cdafound.org\/wp-json\/wp\/v2\/subtheme?post=5706"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}